成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook Chinese Germany Japanese Korean

TargetMol Chemicals Inc. Company Information

Company Name:    TargetMol Chemicals Inc.
Tel:    +1-781-999-5354
Email:    marketing@targetmol.com
Nationality:    United States
WebSite:    https://www.targetmol.com/
Product List:    32080
18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122

Product List
Droxicainide 78289-26-6
DSP-1053 1176326-76-3
DSP-0565 1226855-28-2
Droloxifene 82413-20-5
DRI-C21045 2101765-81-3
DS88790512 2231089-95-3
DS21360717 2304654-43-9
Meclizine dihydrochloride 1104-22-9
DS-1040 Tosylate 1335138-89-0
DREADD agonist 21 56296-18-5
Doxepin D3 Hydrochloride 347840-07-7
MC-DOXHZN;Doxorubicin(6-maleimidocaproyl)hydrazone 151038-96-9
Aldoxorubicin;DOXO-EMCH;INNO-206 1361644-26-9
Doxylamine D5 succinate 1216840-94-6
DPBQ 7029-89-2
DPPH 1898-66-4
DRAK2-IN-1 871837-60-4
Drobuline hydrochloride 68162-52-7
DS08210767 2376334-75-5
DS18561882 2227149-22-4
(Z)-Capsaicin 25775-90-0
DUB-IN-1 924296-18-4
DUB-IN-2 924296-19-5
Pralidoxime Chloride 51-15-0
DU717 59943-31-6
DSR-6434 1059070-10-8
Duloxetine D3 hydrochloride;LY248686 D3 hydrochloride;(S)-Duloxetine D3 hydrochloride 1435727-97-1
Duocarmycin GA 1613286-59-1
Duloxetine metabolite Para-Naphthol Duloxetine;Para-Naphthol duloxetine 949095-98-1
DUB-IN-3 924296-17-3
DuP 105 96800-41-8
Duocarmycin MB 1613286-58-0
2-(Hydroxymethyl)pyridine 586-98-1
Duoperone 62030-88-0
Durlobactam sodium salt 1467157-21-6
DUPA(OtBu)-OH 1026987-94-9
Duocarmycin DM free base;Duocarmycin 1116745-06-2
Duocarmycin SA 130288-24-3
Duocarmycin TM 157922-77-5
Duramycin;Moli1901;Lancovutide 1391-36-2
Duocarmycin MA 1613286-57-9
Imazalil 35554-44-0
Dutogliptin tartrate;PHX-1149 890402-81-0
Durvalumab 1428935-60-7
Duvelisib (R enantiomer);INK1197 R enantiomer;Duvelisib R enantiomer;IPI-145 R enantiomer 1261590-48-0
DVD-445 2375846-41-4
Dutogliptin;PHX-1149 free base 852329-66-9
Ecastolol 77695-52-4
Ecopladib 381683-92-7
E6130 1427058-33-0
DW14800 2243709-60-4
Ciclopirox olamine 41621-49-2
E64FC26 2285446-62-8
Doxylamine succinate 562-10-7
EG00229 1210945-69-9
Eg5 Inhibitor V, trans-24 869304-55-2
Nazartinib mesylate;EGF816 (mesylate) 1508250-72-3
EGFR-IN-1 1625677-63-5
EGFR-IN-2 1643497-70-4
Biotin 58-85-5
DYRKs-IN-1 1387090-01-8
DYRKs-IN-2 1386980-04-6
(E)-10-Hydroxynortriptyline maleate;(E)-10-Hydroxy Nortriptyline maleate 74853-74-0
EC0488 1059477-92-7
EC1454 1602487-15-9
EC359 2012591-09-0
EGFR-IN-1 hydrochloride 2227455-78-7
Ecteinascidin 770;Et-770;Ecteinascidine 770 114899-80-8
Ecteinascidin-Analog-1 874758-58-4
Edaravone-d5;MCI-186 D5;Edaravone D5 1228765-67-0
EG01377 2227996-00-9
Nazartinib S-enantiomer;EGF816 (S-enantiomer) 1508256-20-9
DZ2002 33231-14-0
E-7386 1799824-08-0
(E)-GABAB receptor antagonist 1 1611483-29-4
LHF-535 1450929-77-7
(E/Z)-BCI 15982-84-0
EACC 864941-31-1
EB-47 366454-36-6
EC5026 1809885-32-2
EGFR-IN-7 2267329-76-8
EGFR-IN-5 2225887-26-1
EGFR-IN-8 2407957-87-1
EGFR-IN-9 1226549-39-8
EHMT2-IN-1 2230849-55-3
EGLU 170984-72-2
Dolutegravir intermediate-1 1335210-23-5
Dot1L-IN-2 1940206-71-2
Dofetilide D4;UK 68789 D4 1189700-56-8
Deschloroclozapine 1977-07-7
Dopropidil 79700-61-1
DOV-216,303 Free Base 66504-40-3
Nithiamide 140-40-9
DOTAP chloride 132172-61-3
Dopamine D2 receptor antagonist-1 1055411-77-2
Dofetilide N-oxide;UK-116856 144449-71-8
Dooku1 2253744-54-4
NMI 8739 129024-87-9
Donitriptan 170912-52-4
Dot1L-IN-1 2088518-50-5
18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122

Copyright 2007©  ChemicalBook. All rights reserved.